6 hasil untuk "LABUHN, COLLEEN"
Menampilkan 1–6 · 0,40 detik · RSS
-
Artikel Jurnal Teks lengkap
Physiology and Clinical Utility of HeartMate Pump Parameters
The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump intended for durable support being actively manufactured and implanted for adults in the United States. The changes in preload and afterload that accompany common clinical scenarios experienced by patients with…
-
Artikel Jurnal Teks lengkap
Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes
BACKGROUND: Metabolic impairment is common in heart failure patients. Continuous‐flow left ventricular assist devices (CF‐LVADs) improve hemodynamics and outcomes in patients with advanced heart failure; however, the effect of CF‐LVADs on metabolic status is unknown. This study aims to evaluate the…
-
Artikel Jurnal Teks lengkap
Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation
BACKGROUND: Continuous-flow left ventricular assist devices (LVADs) improve the hemodynamics of patients with advanced heart failure. However, longitudinal trajectories of hemodynamics in LVAD patients remain unknown. The aim of this study was to investigate the trends of hemodynamic parameters…
-
Artikel Jurnal Teks lengkap
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices
Tolvaptan is an effective therapy for heart failure patients with symptomatic congestion and hyponatremia. The efficacy of its use in patients with continuous-flow left ventricular assist devices (LVADs) is unknown. The aim of this study was to assess the clinical efficacy and safety of tolvaptan…
-
Artikel Jurnal Teks lengkap
A Case of Suspected Covid 19 Related Cardiomyopathy
BACKGROUND: The novel SARS-CoV-2 virus causing COVID-19 has been associated with diverse cardiovascular pathology. We present a case of cardiomyopathy due to possible COVID-19 resulting in cardiogenic shock. CASE: A 54 year-old male presented to the hospital with 4 weeks of progressive dyspnea, leg…
-
Artikel Jurnal Teks lengkap
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study
PURPOSE: Tolvaptan, a selective vasopressin type-2 antagonist, has been shown to increase serum sodium (Na) and urine output in hyponatremic left ventricular assist device (LVAD) patients in retrospective studies. In this prospective randomized pilot study, we aimed to assess the efficacy of…